Onderneming NeuroSense Therapeutics Ltd.
Aandelen
NRSN
IL0011809592
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,23 USD | -2,38% | -13,38% | +56,69% |
Vakgebied
Aantal werknemers: 18
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13-02-17 |
Or Eisenberg
DFI | Director of Finance/CFO | 42 | 01-06-21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-12-21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01-01-22 |
Corporate Officer/Principal | - | 01-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 21-12-21 | |
Chairman | 67 | 01-10-21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01-12-21 |
Director/Board Member | 49 | 01-01-22 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 21-12-21 |
Alon Ben-Noon
FOU | Founder | 45 | 13-02-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 17 334 042 | 12 382 922 ( 71,44 %) | 0 | 71,44 % |
Bedrijfsgegevens
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+56,69% | 21,32 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers NRSN
- Onderneming NeuroSense Therapeutics Ltd.